LCM Capital Management’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$355K Buy
1,008
+11
+1% +$3.92K 0.18% 69
2025
Q4
$326K Hold
997
0.16% 75
2025
Q3
$281K Sell
997
-58
-5% -$16.8K 0.14% 85
2025
Q2
$295K Hold
1,055
0.15% 80
2025
Q1
$329K Sell
1,055
-4
-0.4% -$1.18K 0.19% 71
2024
Q4
$276K Hold
1,059
0.16% 78
2024
Q3
$341K Sell
1,059
-4
-0.4% -$1.31K 0.2% 63
2024
Q2
$332K Hold
1,063
0.21% 60
2024
Q1
$302K Hold
1,063
0.2% 66
2023
Q4
$306K Hold
1,063
0.22% 65
2023
Q3
$286K Hold
1,063
0.23% 64
2023
Q2
$236K Hold
1,063
0.19% 75
2023
Q1
$257K Hold
1,063
0.22% 69
2022
Q4
$279K Hold
1,063
0.27% 55
2022
Q3
$240K Hold
1,063
0.25% 62
2022
Q2
$259K Hold
1,063
0.26% 59
2022
Q1
$257K Buy
1,063
+17
+2% +$3.91K 0.21% 73
2021
Q4
$235K Hold
1,046
0.18% 78
2021
Q3
$222K Sell
1,046
-45
-4% -$10.4K 0.19% 78
2021
Q2
$266K Sell
1,091
-45
-4% -$11.1K 0.22% 68
2021
Q1
$283K Sell
1,136
-40
-3% -$9.54K 0.25% 63
2020
Q4
$271K Buy
+1,176
New +$271K 0.26% 58

Other funds holding AMGN

LCM Capital Management's AMGN Position: Q1 2026 in Review

LCM Capital Management increased its Amgen (AMGN) stake by 1.1% in Q1 2026, buying an estimated $3.92K and bringing the position to 1,008 shares worth $355K. The position accounts for 0.18% of the portfolio, ranked #69.

LCM Capital Management first reported a position in AMGN in Q4 2020 and has held it in 22 quarters since. 3,129 funds tracked by Wall St. Rank hold AMGN as of Q1 2026.

  • LCM Capital Management held 1,008 shares of Amgen worth $355K as of Q1 2026.
  • LCM Capital Management bought 11 Amgen shares in Q1 2026, an estimated $3.92K.
  • Amgen made up 0.18% of LCM Capital Management's portfolio in Q1 2026, its #69 holding.
  • LCM Capital Management first reported a position in Amgen in Q4 2020 and has held it in 22 quarters since.
  • 3,129 funds tracked by Wall St. Rank held Amgen as of Q1 2026.

Based on LCM Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.